Cargando…
A single-domain i-body, AD-114, attenuates renal fibrosis through blockade of CXCR4
The G protein–coupled CXC chemokine receptor 4 (CXCR4) is a candidate therapeutic target for tissue fibrosis. A fully human single-domain antibody-like scaffold i-body AD-114-PA600 (AD-114) with specific high binding affinity to CXCR4 has been developed. To define its renoprotective role, AD-114 was...
Autores principales: | Cao, Qinghua, Huang, Chunling, Yi, Hao, Gill, Anthony J., Chou, Angela, Foley, Michael, Hosking, Chris G., Lim, Kevin K., Triffon, Cristina F., Shi, Ying, Chen, Xin-Ming, Pollock, Carol A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876455/ https://www.ncbi.nlm.nih.gov/pubmed/35015734 http://dx.doi.org/10.1172/jci.insight.143018 |
Ejemplares similares
-
Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis
por: Griffiths, K., et al.
Publicado: (2018) -
RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy
por: Shi, Ying, et al.
Publicado: (2020) -
Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4
por: Griffiths, Katherine, et al.
Publicado: (2019) -
Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF-β1/Smad Pathway in Diabetic Mice
por: Huang, Chunling, et al.
Publicado: (2013) -
Metformin Attenuates Renal Fibrosis in a Mouse Model of Adenine-Induced Renal Injury Through Inhibiting TGF-β1 Signaling Pathways
por: Yi, Hao, et al.
Publicado: (2021)